Matthew Shea
Stock Analyst at Needham
(0.85)
# 1,991
Out of 5,128 analysts
45
Total ratings
50%
Success rate
-4.4%
Average return
Main Sectors:
Stocks Rated by Matthew Shea
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALHC Alignment Healthcare | Reiterated: Hold | n/a | $7.50 | - | 1 | Oct 30, 2026 | |
| CLOV Clover Health Investments | Initiated Coverage: Buy | $6 | $4.88 | +22.95% | 1 | Oct 28, 2026 | |
| STLN Starling Oncology | Reiterated: Buy | $7 → $9 | $3.75 | +140.00% | 11 | Oct 14, 2026 | |
| ASTH Astrana Health | Reiterated: Buy | $41 | $31.77 | +29.05% | 4 | Aug 7, 2026 | |
| AGL agilon health | Reiterated: Hold | n/a | $110.30 | - | 9 | Aug 6, 2026 | |
| EVH Evolent Health | Reiterated: Buy | $5 | $4.77 | +4.82% | 12 | Aug 6, 2026 | |
| PRVA Privia Health Group | Reiterated: Buy | $30 | $23.67 | +26.74% | 7 | May 7, 2026 |
Alignment Healthcare
Oct 30, 2026
Reiterated: Hold
Price Target: n/a
Current: $7.50
Upside: -
Clover Health Investments
Oct 28, 2026
Initiated Coverage: Buy
Price Target: $6
Current: $4.88
Upside: +22.95%
Starling Oncology
Oct 14, 2026
Reiterated: Buy
Price Target: $7 → $9
Current: $3.75
Upside: +140.00%
Astrana Health
Aug 7, 2026
Reiterated: Buy
Price Target: $41
Current: $31.77
Upside: +29.05%
agilon health
Aug 6, 2026
Reiterated: Hold
Price Target: n/a
Current: $110.30
Upside: -
Evolent Health
Aug 6, 2026
Reiterated: Buy
Price Target: $5
Current: $4.77
Upside: +4.82%
Privia Health Group
May 7, 2026
Reiterated: Buy
Price Target: $30
Current: $23.67
Upside: +26.74%